---
figid: PMC4090290__nihms553100f1
figlink: /pmc/articles/PMC4090290/figure/F1/
number: Figure 1
caption: Epidermal growth factor receptor (EGFR) pathway activation during HNSCC carcinogenic
  process. Loss of heterozigosity (LOH), EGFR overexpression/amplification and cyclooxygenase-2
  (COX2) dysregulation in pre-malignant lesions have been associated with invasive
  cancer risk. EGFR activation contributes to acquisition of cancer hallmarks represented
  in the figure. EGFR can be inhibited by the use of monoclonal antibodies (cetuximab,
  panitumumab, zalatumumab) and tyrosine kinase inhibitors (erlotinib, gefitinib,
  vandetanib and afatinib). Vandetanib and afatinib exhibit multikinase activity against
  other targets such as the vascular endothelial growth factor (VEGF) receptor (vandetanib)
  and HER-2 (afatinib).
pmcid: PMC4090290
papertitle: Targeting the Epidermal Growth Factor Receptor for Head and Neck Cancer
  Chemoprevention.
reftext: Milena P. Mak, et al. Oral Oncol. ;50(10):918-923.
pmc_ranked_result_index: '102043'
pathway_score: 0.96117
filename: nihms553100f1.jpg
figtitle: Epidermal growth factor receptor (EGFR) pathway activation during HNSCC
  carcinogenic process
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4090290__nihms553100f1.html
  '@type': Dataset
  description: Epidermal growth factor receptor (EGFR) pathway activation during HNSCC
    carcinogenic process. Loss of heterozigosity (LOH), EGFR overexpression/amplification
    and cyclooxygenase-2 (COX2) dysregulation in pre-malignant lesions have been associated
    with invasive cancer risk. EGFR activation contributes to acquisition of cancer
    hallmarks represented in the figure. EGFR can be inhibited by the use of monoclonal
    antibodies (cetuximab, panitumumab, zalatumumab) and tyrosine kinase inhibitors
    (erlotinib, gefitinib, vandetanib and afatinib). Vandetanib and afatinib exhibit
    multikinase activity against other targets such as the vascular endothelial growth
    factor (VEGF) receptor (vandetanib) and HER-2 (afatinib).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK11
  - MAPK12
  - PIK3R4
  - PIK3R5
  - RAF1
  - PIK3CB
  - PIK3R3
  - AKT3
  - MAPK9
  - MAPK8
  - PIK3R6
  - JAK2
  - ARAF
  - MTOR
  - EGFR
  - VEGFB
  - EGF
  - PIK3CA
  - MAPK1
  - MAPK13
  - KRAS
  - BRAF
  - MAPK10
  - AKT2
  - MAPK14
  - TGFA
  - AKT1
  - VEGFC
  - PIK3CD
  - PIK3CG
  - VEGFD
  - HRAS
  - PGF
  - VEGFA
  - MAPK3
  - STAT3
  - NRAS
  - Vandetanib
  - Cancer
  - Lung cancer
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: TGFA
  symbol: TGFA
  source: hgnc_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
chemicals:
- word: Vandetanib
  source: MESH
  identifier: C452423
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
---
